A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia

Chonbuk National University

Status and phase

Completed

Phase 3

Phase 2

Conditions

Hyperlipidemia

Treatments

Dietary Supplement: Placebo powder

Dietary Supplement: Aged garlic powder

Study type

Interventional

Funder types

Other

Identifiers

NCT01402102

Doul-BGarlic-001

Details and patient eligibility

About

We performed a double-blind parallel study in a group of mildly hypercholesterolemic subjects who were given aged garlic powder over a period of 12 weeks. We measured serum lipids, including total cholesterol, low-density-lipoprotein (LDL) and high-density-lipoprotein (HDL) cholesterol, and triglycerides, and monitored their blood pressure.

Full description

An increased serum cholesterol level is an important risk factor for the development of cardiovascular and cerebrovascular disease. Reduction of these and other risk factors through dietary modification, behavioral changes, and medicinal intervention has already substantially decreased the incidence and mortality from cardiovascular and cerebrovascular disease. Supplementation of the diet with certain biofactors may further reduce such risk factors. Aged garlic belongs to a group of dietary supplements that may lessen the incidence of cardiovascular and cerebrovascular disease by reducing lipids levels and decreasing platelet responsiveness to activating agents.

Enrollment

60 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Mild hypercholesterolemic subjects aged from 20 to 80 years
had no received lipid-lowering drugs for at least 3 months prior to the recruitment

Exclusion criteria

self-reported pregnancy,lactation
prevalent heart disease,cancer,renal disorder, or diabetes mellitus, and use of lipid or antihypertensive medications